Page last updated: 2024-08-25

methotrexate and Myocardial Ischemia

methotrexate has been researched along with Myocardial Ischemia in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Hirosawa, T; Katsukura, S; Shimizu, T1
Chen, J; Cooper, D; Norling, LV1
Kaneko, Y; Takanashi, S; Takeuchi, T1
Aleman, BM; Boekel, NB; Gietema, JA; Poortmans, P; Rietveld, DH; Russell, NS; Rutgers, EJ; Schaapveld, M; Schinagl, DA; Theuws, JC; van Leeuwen, FE; Versteegh, MI; Visser, O1
Gottschall, CA; Moreira, DM; Vieira, JL1
Chang, YT; Chen, CM; Chen, TT; Chen, YJ; Shen, JL; Wang, CB; Wu, CY1
Alivernini, S; De Santis, M; Ferraccioli, G; Loperfido, F; Verrillo, A; Zoli, A1
Igawa, M; Kadena, H; Matsuura, H; Ohkuchi, T; Ueda, M; Usui, T1
Erb, N; Kitas, GD1

Reviews

1 review(s) available for methotrexate and Myocardial Ischemia

ArticleYear
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation.
    Cells, 2021, 04-13, Volume: 10, Issue:4

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Etanercept; Heart Failure; Humans; Hydroxychloroquine; Inflammation; Methotrexate; Myocardial Infarction; Myocardial Ischemia; Risk Factors; Stroke Volume; Sulfasalazine

2021

Trials

1 trial(s) available for methotrexate and Myocardial Ischemia

ArticleYear
The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).
    Journal of cardiac failure, 2009, Volume: 15, Issue:10

    Topics: Aged; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Physical Endurance; Recovery of Function; Treatment Outcome

2009

Other Studies

7 other study(ies) available for methotrexate and Myocardial Ischemia

ArticleYear
SAPHO Syndrome.
    The American journal of the medical sciences, 2020, Volume: 359, Issue:1

    Topics: Acquired Hyperostosis Syndrome; Antirheumatic Agents; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia

2020
Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:11

    Topics: Abatacept; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Comorbidity; Drug Resistance; Female; Fractures, Bone; Glucocorticoids; Humans; Hypertension; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Prednisolone; Renal Insufficiency, Chronic; Severity of Illness Index; Stroke; Tumor Necrosis Factor Inhibitors

2021
Cardiovascular Disease Risk in a Large, Population-Based Cohort of Breast Cancer Survivors.
    International journal of radiation oncology, biology, physics, 2016, Apr-01, Volume: 94, Issue:5

    Topics: Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Intraductal, Noninfiltrating; Cardiovascular Diseases; Cause of Death; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Combined Modality Therapy; Confidence Intervals; Female; Fluorouracil; Heart; Heart Failure; Heart Valve Diseases; Humans; Lymphatic Irradiation; Mastectomy; Methotrexate; Middle Aged; Myocardial Ischemia; Netherlands; Radiotherapy; Registries; Risk Assessment; Survivors; Time Factors; Unilateral Breast Neoplasms

2016
Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
    Arthritis and rheumatism, 2012, Volume: 64, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Psoriatic; Cohort Studies; Comorbidity; Databases, Factual; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Psoriasis; Retrospective Studies; Risk; Risk Factors; Taiwan

2012
Lupus anticoagulant and ischemic myocardial microangiopathy in rheumatoid arthritis.
    Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:6

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Clopidogrel; Echocardiography; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Coagulation Inhibitor; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prednisolone; Radionuclide Imaging; Sialoglycoproteins; Ticlopidine

2006
Myocardial ischemia after treatment with methotrexate, etoposide and cisplatin.
    Urologia internationalis, 1993, Volume: 50, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Myocardial Ischemia; Urinary Bladder Neoplasms

1993
Homocysteine modulation as a reason for continuous folic acid supplementation in methotrexate-treated rheumatoid arthritis patients.
    Rheumatology (Oxford, England), 2001, Volume: 40, Issue:6

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Dietary Supplements; Folic Acid; Homocysteine; Humans; Methotrexate; Myocardial Ischemia

2001